All Sites This Site

    Find a Program

    Find a Lab

    Laboratory Director

    David M. Jablons, M.D.


    David M. Jablons, M.D.

    Professor of Surgery, Director, Thoracic Oncology Lab

    About the Lab »

    Lung Cancer Systems Genetics

    An Approach to Individualized Lung Cancer Diagnosis & Therapy

    Featured Research »

    Support the Lab

    Your gift to the Thoracic Oncology Lab helps scientists discover new treatments and cures for lung cancer, esophegeal cancer and mesothelioma.

    Read more »

    On the road to discovery.... Wnt Signalling, Diagnostics Development, Molecular Targeted Therapeutics

    Cancer treatment is rapidly proceeding towards the era of personalized medicine where treatment is based on the distinctive molecular characteristics of a patient's tumor. This knowledge will allow patients to receive novel combinations of therapies that will maximize clinical benefit, more accurately predict disease outcome, and allow patients at the highest risk of relapse to receive the most aggressive treatment.

    The Thoracic Oncology Lab is pursuing a variety of strategies to treat and cure lung cancer, mesothelioma and esophageal cancer. These include the investigation of molecular pathways such as Wnt and Hh, the role of inflammation in lung carcinogenesis, isolation of lung cancer stems cells, and the Lung Cancer Systems Genetics Project, An Approach to Individualized Lung Cancer Diagnosis and Therapy. Eventually, these efforts will have a major impact on these diseases.

    Featured Publications

    Chou J, Lin YC, Kim J, You L, Xu Z, He B, Jablons DM.
    Nasopharyngeal carcinoma-Review of the molecular mechanisms of tumorigenesis.
    Head and Neck , [In Press] May-29-2008; Volume 9999 Issue 9999 - : Epub ahead of print
    Clément G, Guilleret I, He B, Yagui-Beltrán A, Lin YC, You L, Xu Z, Shi Y, Okamoto J, Benhattar J, Jablons D
    Epigenetic alteration of the Wnt inhibitory factor-1 promoter occurs early in the carcinogenesis of Barrett's esophagus.
    Cancer Sci, Jan-01-2008; 991: 46-53
    Reich J, Asaph J, Raz DJ, Jablons DM
    Natural history of stage I lung cancer.
    Chest, Dec-01-2007; 1326: 2062-3
    Uematsu K, Seki N, Seto T, Isoe C, Tsukamoto H, Mikami I, You L, He B, Xu Z, Jablons DM, Eguchi K
    Targeting the Wnt signaling pathway with dishevelled and cisplatin synergistically suppresses mesothelioma cell growth.
    Anticancer Res, Dec-01-2007; 276B: 4239-42
    Shi Y, He B, Kuchenbecker KM, You L, Xu Z, Mikami I, Yagui-Beltran A, Clement G, Lin YC, Okamoto J, Bravo DT, Jablons DM
    Inhibition of Wnt-2 and galectin-3 synergistically destabilizes beta-catenin and induces apoptosis in human colorectal cancer cells.
    Int J Cancer, Sep-15-2007; 1216: 1175-81
    Shi Y, He B, You L, Jablons DM
    Roles of secreted frizzled-related proteins in cancer.
    Acta Pharmacol Sin, Sep-01-2007; 289: 1499-504
    Raz DJ, Kim JY, Jablons DM
    Diagnosis and treatment of bronchioloalveolar carcinoma.
    Curr Opin Pulm Med, Jul-01-2007; 134: 290-6
    Raz DJ, Zell JA, Ou SH, Gandara DR, Anton-Culver H, Jablons DM
    Natural history of stage I non-small cell lung cancer: implications for early detection.
    Chest, Jul-01-2007; 1321: 193-9
    Raz DJ, Jablons DM
    EGFR expression and mutational analysis as a predictive test.
    J Clin Oncol, May-20-2007; 2515: 2144; author reply 2144-5
    Raz DJ, Jablons DM
    Five-gene signature in non-small-cell lung cancer.
    N Engl J Med, Apr-12-2007; 35615: 1582; author reply 1583
    Lin YC, You L, Xu Z, He B, Yang CT, Chen JK, Mikami I, Clément G, Shi Y, Kuchenbecker K, Okamoto J, Kashani-Sabet M, Jablons DM
    Wnt Inhibitory Factor-1 Gene Transfer Inhibits Melanoma Cell Growth.
    Hum Gene Ther, Apr-01-2007; 184: 379-386
    View all Publications »